Resolvin D1 suppresses pannus formation via decreasing connective tissue growth factor caused by upregulation of miRNA-146a-5p in rheumatoid arthritis
Open Access
- 27 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Arthritis Research & Therapy
- Vol. 22 (1), 1-14
- https://doi.org/10.1186/s13075-020-2133-2
Abstract
Background Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by inflammation and joint stiffness, finally leading to tissue destruction. Connective tissue growth factor (CTGF) is a critical factor in RA progression, which promotes fibroblast-like synoviocyte (FLS) proliferation, pannus formation, and the damage of cartilage as well as bone. Resolvin D1 (RvD1) can promote inflammation resolution in acute inflammatory diseases, and recently, effects of RvD1 on chronic inflammatory diseases also attracted attention. This study aimed to examine the effect of RvD1 on pannus formation in RA and the underlying mechanism. Methods Serum levels of RvD1 and CTGF were determined in RA patients and healthy persons by UPLC-MS/MS and ELISA respectively. The levels of CTGF and inflammatory factors were assessed by qRT-PCR and ELISA. MicroRNA expression profile was determined by miRNA microarray. The effects of CTGF, RvD1, and miR-146a-5p on angiogenesis were evaluated with tube formation and chick chorioallantoic membrane (CAM) assays. Collagen-induced arthritis (CIA) mice were constructed to detect the effects of RvD1 and miR146a-5p on RA. STAT3 activation was determined by Western blotting. Results RvD1 levels decreased while CTGF levels increased in RA patients' serum, and an inverse correlation of the concentrations of RvD1 and CTGF in the serum of RA patients was synchronously observed. In CIA mice, RvD1 suppressed angiopoiesis and decreased the expression of CTGF. Simultaneously, RvD1 significantly decreased CTGF and pro-inflammation cytokines levels in RA FLS. Furthermore, CTGF suppressed angiopoiesis and RvD1 inhibited the proliferation and migration of RA FLS and angiopoiesis. MiRNA microarray and qRT-PCR results showed that RvD1 upregulated miRNA-146a-5p. The transfection experiments demonstrated that miRNA-146a-5p could decrease inflammatory factors and CTGF levels. Moreover, miRNA-146a-5p decreased the proliferation of FLS and angiogenesis in vivo. MiRNA-146a-5p also suppressed angiogenesis and downregulated the expression of CTGF in CIA mice. Finally, Western blot results revealed that miRNA-146a-5p inhibited the activation of STAT3. Conclusion RvD1 is prone to alleviate RA progression through the upregulation of miRNA-146a-5p to suppress the expression of CTGF and inflammatory mediators, thereby decreasing pannus formation and cartilage damage.Funding Information
- Natural Science Foundation of Zhejiang Province (LQ17H190005)
- Public Technology Applied Research Foundation of Zhejiang Province of China (LGF18H060009)
- the Administration of Zhejiang Traditional Chinese Medicine (2016ZA136)
- National Natural Science Foundation of China (81472055, 81672129)
- Key Research and Development Program of Zhejiang Province (2019C03023)
- Zhejiang College Students Innovative Entrepreneurial Training Program (2018R413011)
This publication has 39 references indexed in Scilit:
- IL6/STAT3 axis mediates resistance to BRAF inhibitors in thyroid carcinoma cellsCancer Letters, 2018
- Mice with miR-146a deficiency develop severe gouty arthritis via dysregulation of TRAF 6, IRAK 1 and NALP3 inflammasomeArthritis Research & Therapy, 2018
- Anti-TNF therapy: past, present and futureInternational Immunology, 2014
- Pro-resolving lipid mediators are leads for resolution physiologyNature, 2014
- Assays to Examine Endothelial Cell Migration, Tube Formation, and Gene Expression ProfilesMethods in Molecular Biology, 2014
- Transforming Growth Factor-β (TGF-β)-mediated Connective Tissue Growth Factor (CTGF) Expression in Hepatic Stellate Cells Requires Stat3 Signaling ActivationOnline Journal of Public Health Informatics, 2013
- The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in ratsBritish Journal of Pharmacology, 2011
- miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in miceThe Journal of Experimental Medicine, 2011
- MicroRNAs in resolution of acute inflammation: identification of novel resolvin Dl‐miRNA circuitsThe FASEB Journal, 2010
- CCN proteins: multifunctional signalling regulatorsThe Lancet, 2004